106 related articles for article (PubMed ID: 24968917)
21. Age-specific HPV seroprevalence among young females in The Netherlands.
Kramer M; Mollema L; Smits G; Boot H; de Melker H; van der Klis F
Sex Transm Infect; 2010 Dec; 86(7):494-9. PubMed ID: 20519252
[TBL] [Abstract][Full Text] [Related]
22. A Bivariate Mixture Model for Natural Antibody Levels to Human Papillomavirus Types 16 and 18: Baseline Estimates for Monitoring the Herd Effects of Immunization.
Vink MA; Berkhof J; van de Kassteele J; van Boven M; Bogaards JA
PLoS One; 2016; 11(8):e0161109. PubMed ID: 27537200
[TBL] [Abstract][Full Text] [Related]
23. [Vaccination against HPV in adults].
Gil Á
Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():22-5. PubMed ID: 20084345
[No Abstract] [Full Text] [Related]
24. Pre-vaccination seroprevalence of 15 human papillomavirus (HPV) types among women in the population-based Slovenian cervical screening program.
Učakar V; Jelen MM; Faust H; Poljak M; Dillner J; Klavs I
Vaccine; 2013 Oct; 31(43):4935-9. PubMed ID: 23994822
[TBL] [Abstract][Full Text] [Related]
25. No evidence for cross-protection of the HPV-16/18 vaccine against HPV-6/11 positivity in female STI clinic visitors.
Woestenberg PJ; King AJ; van der Sande MA; Donken R; Leussink S; van der Klis FR; Hoebe CJ; Bogaards JA; van Benthem BH; ;
J Infect; 2017 Apr; 74(4):393-400. PubMed ID: 28126492
[TBL] [Abstract][Full Text] [Related]
26. Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy.
Carozzi F; Puliti D; Ocello C; Anastasio PS; Moliterni EA; Perinetti E; Serradell L; Burroni E; Confortini M; Mantellini P; Zappa M; Dominiak-Felden G
BMC Infect Dis; 2018 Jan; 18(1):38. PubMed ID: 29334901
[TBL] [Abstract][Full Text] [Related]
27. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana.
Firnhaber C; Evans D; Friedman-Khalili R; Willliams S; Michelow P; Matlhagela K; Wester C; Grinsztejn B; Lockman S
J Clin Virol; 2011 Nov; 52(3):265-8. PubMed ID: 21908233
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and distribution of HPV genotypes and cervical-associated lesions in sexually active young French women following HPV vaccine.
Bretagne CH; Jooste V; Guenat D; Riethmuller D; Bouvier AM; Bedgedjian I; Prétet JL; Valmary-Degano S; Mougin C
J Gynecol Obstet Hum Reprod; 2018 Dec; 47(10):525-531. PubMed ID: 29807205
[TBL] [Abstract][Full Text] [Related]
29. Seroepidemiology and high negativity of IgG antibodies against human papillomavirus (HPV) Type 6, 11, 16, and 18 virus-like particles in women of childbearing age in Port Harcourt, Nigeria.
Okonko IO; Ofoedu V; Okerentugba PO; Frank-Peterside N
J Immunoassay Immunochem; 2015; 36(2):210-20. PubMed ID: 24824952
[TBL] [Abstract][Full Text] [Related]
30. Skin and mucosal human papillomavirus seroprevalence in persons with Fanconi Anemia.
Katzenellenbogen RA; Carter JJ; Stern JE; Butsch Kovacic MS; Mehta PA; Sauter SL; Galloway DA; Winer RL
Clin Vaccine Immunol; 2015 Apr; 22(4):413-20. PubMed ID: 25651924
[TBL] [Abstract][Full Text] [Related]
31. Seroprevalence of mucosal and cutaneous human papillomavirus (HPV) types among children and adolescents in the general population in Germany.
Loenenbach A; Pawlita M; Waterboer T; Harder T; Poethko-Müller C; Thamm M; Lachmann R; Deleré Y; Wichmann O; Wiese-Posselt M
BMC Infect Dis; 2022 Jan; 22(1):44. PubMed ID: 35012452
[TBL] [Abstract][Full Text] [Related]
32. Seroprevalence and risk factors for human papillomavirus in Taiwan.
Wang IJ; Viscidi R; Hwang KC; Lin TY; Chen CJ; Huang LM; Chen HH; Chen CJ
J Trop Pediatr; 2008 Feb; 54(1):14-8. PubMed ID: 17984124
[TBL] [Abstract][Full Text] [Related]
33. Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study.
Romanowski B; Schwarz TF; Ferguson L; Peters K; Dionne M; Behre U; Schulze K; Hillemanns P; Suryakiran P; Thomas F; Struyf F
Hum Vaccin Immunother; 2016; 12(1):20-9. PubMed ID: 26176261
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus-specific antibody status among unvaccinated subjects in the region of Vojvodina, Serbia.
Kovačević G; Božić Nedeljković B; Patić A; Radovanov J; Hrnjaković-Cvjetković I
Cent Eur J Public Health; 2023 Mar; 31(1):57-62. PubMed ID: 37086422
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and seroprevalence of high-risk human papillomavirus infection.
Kim MA; Oh JK; Chay DB; Park DC; Kim SM; Kang ES; Kim JH; Cho CH; Shin HR; Seo K
Obstet Gynecol; 2010 Oct; 116(4):932-940. PubMed ID: 20859158
[TBL] [Abstract][Full Text] [Related]
36. Population dynamics of serologically identified coinfections with human papillomavirus types 11, 16, 18 and 31 in fertile-aged Finnish women.
Kaasila M; Koskela P; Kirnbauer R; Pukkala E; Surcel HM; Lehtinen M
Int J Cancer; 2009 Nov; 125(9):2166-72. PubMed ID: 19585500
[TBL] [Abstract][Full Text] [Related]
37. Long-term persistence of systemic and mucosal immune response to HPV-16/18 AS04-adjuvanted vaccine in preteen/adolescent girls and young women.
Petäjä T; Pedersen C; Poder A; Strauss G; Catteau G; Thomas F; Lehtinen M; Descamps D
Int J Cancer; 2011 Nov; 129(9):2147-57. PubMed ID: 21190190
[TBL] [Abstract][Full Text] [Related]
38. Antibody responses to 26 skin human papillomavirus types in the Netherlands, Italy and Australia.
Waterboer T; Neale R; Michael KM; Sehr P; de Koning MNC; Weißenborn SJ; Sampogna F; Abeni D; Green AC; Bouwes Bavinck JN; Pawlita M; The Epi-Hpv-Uv-Ca Group
J Gen Virol; 2009 Aug; 90(Pt 8):1986-1998. PubMed ID: 19386782
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and seroprevalence of low-risk human papillomavirus in Korean women.
Kim MA; Oh JK; Kim BW; Chay D; Park DC; Kim SM; Kang ES; Kim JH; Cho CH; Shin HR; Seo K
J Korean Med Sci; 2012 Aug; 27(8):922-8. PubMed ID: 22876060
[TBL] [Abstract][Full Text] [Related]
40. Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The Netherlands.
Scherpenisse M; Mollers M; Schepp RM; Boot HJ; Meijer CJ; Berbers GA; van der Klis FR; de Melker HE
PLoS One; 2012; 7(11):e48807. PubMed ID: 23152809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
